Type 2 Diabetes Mellitus clinical trials

Explore recruiting type 2 diabetes mellitus clinical trials.

Recruiting type 2 diabetes mellitus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 2 Diabetes Mellitus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of oral controlled-ileal-release nicotinic acid (CIR-NA) for inducing remission in subjects with prediabetes

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-blind, Placebo-controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Effect of Steady-state AZD6793 on the Steady-state Pharmacokinetics/Pharmacodynamics of Metformin in Participants with Type 2 Diabetes Mellitus

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2 Randomized, Double-blind, Placebo‑controlled, Dose‑ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Subjects With Type 2 Diabetes Mellitus

Austria, Italy, Sweden, Hungary, Romania, Greece +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia in people with and without diabetes

Austria

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A research study comparing different ways of increasing the dose of NNC0519-0130 in participants with overweight or obesity

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

Type 2 Diabetes Mellitus trials by city

Type 2 Diabetes Mellitus in Toronto Type 2 Diabetes Mellitus in Vancouver Type 2 Diabetes Mellitus in Montreal Type 2 Diabetes Mellitus in Calgary Type 2 Diabetes Mellitus in Edmonton Type 2 Diabetes Mellitus in Ottawa Type 2 Diabetes Mellitus in Winnipeg Type 2 Diabetes Mellitus in Quebec City Type 2 Diabetes Mellitus in Hamilton Type 2 Diabetes Mellitus in Kitchener Type 2 Diabetes Mellitus in London Type 2 Diabetes Mellitus in Halifax Type 2 Diabetes Mellitus in New York Type 2 Diabetes Mellitus in Los Angeles Type 2 Diabetes Mellitus in Chicago Type 2 Diabetes Mellitus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease